NSE · Healthcare · Drug Manufacturers - General
with an average price target of ₹5,855.00.
| Document | Date |
|---|---|
| Annual report FY2025 SANOFI CONSUMER HEALTHCARE INDIA LIMITED - ANNUAL REPORT 2025 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹8,784 million, up 21% year-on-yea | 2026-06-04 |
| Quarterly results · Q4 FY26 SANOFI CONSUMER HEALTHCARE INDIA LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q4 2026 Revenue from Operations: ₹2,292 million (vs ₹1,726 million i | 2026-04-28 |
| Q3 FY26 earnings call SANOFI CONSUMER HEALTHCARE INDIA LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹880 crore turnover • Profit from Operations | 2026-03-27 |
| Investor presentation · Q3 FY26 SANOFI CONSUMER HEALTHCARE INDIA LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • FY 2025 Revenue from Operations: ₹8,784 Million • Profit from Operati | 2026-03-24 |
| Quarterly results · Q3 FY26 SANOFI CONSUMER HEALTHCARE INDIA LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from Operations (FY 2025): INR 8,784 million vs INR 7,245 mi | 2026-02-25 |
| Quarterly results · Q2 FY26 SANOFI CONSUMER HEALTHCARE INDIA LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 2025 Revenue: ₹2,339 million, up 46% year-on-year (vs ₹1,599 mill | 2025-11-12 |
| Quarterly results · Q1 FY26 SANOFI CONSUMER HEALTHCARE INDIA LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 FY2025 (Quarter ended June 30, 2025): - Revenue from Operations | 2025-08-04 |
| Annual report FY2024 SANOFI CONSUMER HEALTHCARE INDIA LIMITED - DOCUMENT SUMMARY HEADLINE NUMBERS • Revenue: ₹7,245 million (FY 2024) • EBITDA: ₹2,552 million with 35% E | 2025-04-23 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹75 / share ex-date Jun 19, 2026 | 2026-06-19 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SANOFI CONS HEALTHC IND L — free to start.
Google PlayApp StoreData updated 2026-09-18.